Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.

Bradstock, K

Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia. [electronic resource] - Leukemia Sep 2001 - 1331-8 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0887-6924

10.1038/sj.leu.2402218 doi


Acute Disease
Adjuvants, Immunologic--economics
Adult
Cost-Benefit Analysis
Cytarabine--administration & dosage
Female
Glycosylation
Granulocyte Colony-Stimulating Factor--economics
Humans
Idarubicin--economics
Lenograstim
Leukemia, Myeloid--drug therapy
Male
Middle Aged
Recombinant Proteins--economics
Survival Rate